Fig. 3
From: Sertaconazole-repurposed nanoplatform enhances lung cancer therapy via CD44-targeted drug delivery
The anti-lung cancer effect of HTS NPs in vitro. (A-B) The viability of H460 and A549 cells following treatment with TPGS, STZ TS NPs and HTS NPs at different concentrations (n = 3). (C) LDH assay of H460 and A549 cells co-cultured with TPGS, STZ, TS NPs and HTS NPs (n = 3). (D) Images of the effects of morphology on H460 and A549 lung cancer cells with different formulations. Scale bar: 50 μm. (E-F) Colony formation assay and quantitative analysis of H460 and A549 lung cancer cells (n = 3). (G-H) H460 and A549 cells co-cultured with different groups using the EdU assay (n = 3). Scale bar: 50 μm. The error bars represent the means ± SD (***P < 0.001)